| Identification | Back Directory | [Name]
2-O-benzoyl-3-O-t-butyldiphenylsilyl-L-threonolactone | [CAS]
1446785-28-9 | [Synonyms]
2-O-benzoyl-3-O-t-butyldiphenylsilyl-L-threonolactone
2-O-Benzoyl-3-O-tert-butyldiphenylsilyl-L-threonolactone
4-[(tert-Butyldiphenylsilyl)oxy]-2-oxo-3-tetrahydrofuryl (3R,4S)-Benzoate
2(3H)-Furanone, 3-(benzoyloxy)-4-[[(1,1-dimethylethyl)diphenylsilyl]oxy]dihydro-, (3R,4S)- | [Molecular Formula]
C27H28O5Si | [MDL Number]
MFCD31707502 | [MOL File]
1446785-28-9.mol | [Molecular Weight]
460.59 |
| Hazard Information | Back Directory | [Uses]
2-O-Benzoyl-3-O-t-butyldiphenylsilyl-L-threono lactone is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|